Literature DB >> 16954401

Mice naturally resistant to Yersinia pestis Delta pgm strains commonly used in pathogenicity studies.

Yasemin H K Congleton1, Christine R Wulff, Edward J Kerschen, Susan C Straley.   

Abstract

We report that females of some substrains of inbred mouse strain 129 are resistant to systemic plague due to conditionally virulent Deltapgm strains of Yersinia pestis; however, fully virulent Y. pestis is not attenuated in these mice. Therefore, these mice offer a powerful system in which to map in parallel host resistance traits and opposing bacterial virulence properties for plague.

Entities:  

Mesh:

Year:  2006        PMID: 16954401      PMCID: PMC1695521          DOI: 10.1128/IAI.00597-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains.

Authors:  S M Jones; F Day; A J Stagg; E D Williamson
Journal:  Vaccine       Date:  2000-09-15       Impact factor: 3.641

Review 2.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

3.  Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.

Authors:  Alexander V Philipovskiy; Clarissa Cowan; Christine R Wulff-Strobel; Sandra H Burnett; Edward J Kerschen; Donald A Cohen; Alan M Kaplan; Susan C Straley
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus.

Authors:  Céline Pujol; Jens P Grabenstein; Robert D Perry; James B Bliska
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-24       Impact factor: 11.205

Review 5.  Yersinia pestis--etiologic agent of plague.

Authors:  R D Perry; J D Fetherston
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.

Authors:  Edward J Kerschen; Donald A Cohen; Alan M Kaplan; Susan C Straley
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Transmission of Yersinia pestis from an infectious biofilm in the flea vector.

Authors:  Clayton O Jarrett; Eszter Deak; Karen E Isherwood; Petra C Oyston; Elizabeth R Fischer; Adeline R Whitney; Scott D Kobayashi; Frank R DeLeo; B Joseph Hinnebusch
Journal:  J Infect Dis       Date:  2004-07-12       Impact factor: 5.226

8.  In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae.

Authors:  T Une; R R Brubaker
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

9.  Evolutionary genetics: CCR5 mutation and plague protection.

Authors:  Joan Mecsas; Greg Franklin; William A Kuziel; Robert R Brubaker; Stanley Falkow; Donald E Mosier
Journal:  Nature       Date:  2004-02-12       Impact factor: 49.962

10.  Granulocyte function in grancalcin-deficient mice.

Authors:  Jürgen Roes; B Ken Choi; David Power; Ping Xu; Anthony W Segal
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

  10 in total
  11 in total

1.  The resistance of BALB/cJ mice to Yersinia pestis maps to the major histocompatibility complex of chromosome 17.

Authors:  Joshua K Turner; Milton M McAllister; John L Xu; Richard I Tapping
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

2.  Resistance of Mice of the 129 Background to Yersinia pestis Maps to Multiple Loci on Chromosome 1.

Authors:  Michael Tencati; Richard I Tapping
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

3.  Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice.

Authors:  Nathaniel D Lambert; Deanna M Langfitt; Matthew L Nilles; David S Bradley
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

Review 4.  Enterobacteria and host resistance to infection.

Authors:  Eugene Kang; Alanna Crouse; Lucie Chevallier; Stéphanie M Pontier; Ashwag Alzahrani; Navoun Silué; François-Xavier Campbell-Valois; Xavier Montagutelli; Samantha Gruenheid; Danielle Malo
Journal:  Mamm Genome       Date:  2018-05-21       Impact factor: 2.957

5.  Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.

Authors:  Joseph B McPhee; Patricio Mena; Yue Zhang; James B Bliska
Journal:  Infect Immun       Date:  2012-04-30       Impact factor: 3.441

6.  Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice.

Authors:  Joshua K Turner; John L Xu; Richard I Tapping
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

7.  Absence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis.

Authors:  Hanni Lee-Lewis; Deborah M Anderson
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

8.  The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses.

Authors:  R Kingston; F Burke; J H Robinson; P A Bedford; S M Jones; S C Knight; E D Williamson
Journal:  Clin Exp Immunol       Date:  2007-07-23       Impact factor: 4.330

9.  Difference in Strain Pathogenicity of Septicemic Yersinia pestis Infection in a TLR2-/- Mouse Model.

Authors:  Kyle L O'Donnell; Peter L Knopick; Riley Larsen; Sanghita Sarkar; Matthew L Nilles; David S Bradley
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

10.  Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.

Authors:  Gabriela Mellado-Sanchez; Karina Ramirez; Cinthia B Drachenberg; Jovita Diaz-McNair; Ana L Rodriguez; James E Galen; James P Nataro; Marcela F Pasetti
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-11-26       Impact factor: 2.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.